Data temporarily unavailable
Unable to load analysis for « - » for now. Try again in a few moments.
Investlytic score: 2/5 criteria met. Data as of 01/11/2026.
- ❌ Price trend failed
- ⚠️ Mixed growth
- ✅ Debt passed
- ✅ P/E passed
- ❌ Correction failed
Price trend
Overall trend (8 years): insufficient progression (less than x1.5).
Price change 2020 → 2021: -58.43%
Price change 2021 → 2022: -81.23%
Price change 2022 → 2023: -32.22%
Price change 2023 → 2024: -21.56%
Price change 2024 → 2025: 19.87%
Price change 2025 → 2026: 7.46%
Price change 2026 (year to date): 0.26%
Financial growth
Revenue CAGR (7 years): 86.13%
Earnings CAGR (7 years): N/A
Growth status: positive trend (>1%/yr) in revenue, earnings data insufficient/N/A.
Debt
Debt-to-equity ratio: 0.06
Debt/equity < 0.5 (maximum threshold).
P/E (Price/Earnings)
P/E ratio: 4.50
P/E < 25.0 (maximum threshold).
Correction (6 months)
Price history over 6 months not available.
Criteria of the Investlytic model
- / 5Free with the Investlytic logo. Paste this line into your page: options.
<script src="https://investlytic.co/encart.js" data-symbole="5CV.DE" data-lang="en"></script>Price trend
Price & trend
Interactive chart →💰 Dividend
Dividend ranking →⚖️ Comparison with the market
All stocks →| Stock | P/E | Dette/FP | Revenue growth | Rating |
|---|
Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.
Detailed analysis · Price trend
-
Revenues & profits
Revenue and net income
Financial indicators
Annual financial statements
| Fiscal year | Revenue | Net income | Net margin | EPS | Revenue growth |
|---|
Dividends and earnings
CureVac N.V.: dividend history, last distributions, stock splits and earnings releases.
No known dividend for this company.
Earnings releases
| Date | Published EPS | Expected EPS | Surprise |
|---|---|---|---|
| 15/08/2025 | -0.26 | -0.18 | n/a |
| 20/05/2025 | -0.23 | -0.18 | n/a |
| 10/04/2025 | -0.15 | -0.21 | n/a |
| 12/11/2024 | 1.51 | 1.41 | +7.1 % |
| 15/08/2024 | -0.32 | -0.28 | n/a |
| 23/05/2024 | -0.31 | -0.20 | n/a |
Factual data: ex-dividend history and earnings calendar, as of 21/11/2026. A past dividend does not guarantee the next one.
PEA and practical information
Rule applied: the French PEA accepts shares of companies headquartered in the European Union or the European Economic Area and subject to corporate income tax; ADRs and tax-exempt property companies (SIIC) are excluded. The institution holding the PEA confirms eligibility.
Frequently asked questions about CureVac N.V.
Is CureVac N.V. stock eligible for the French PEA?
Likely: the company is headquartered in the European Union or the European Economic Area (ISIN NL0015436031) and the stock is listed on a European exchange. The institution holding the PEA confirms eligibility.
How many employees does CureVac N.V. have?
825 full-time employees according to the latest published profile.
Who runs CureVac N.V.?
Alexander Zehnder is the company's chief executive.